- Expertise article
- Robbins et al., 2013
A recent study showed Porcine Reproductive and Respiratory Syndrome (PRRS) costs the US pork industry $1.8 million per day. Controlling this disease in large production systems is challenging, but considered one of the most important drivers for keeping systems producing at target levels.
Approximately 88% of losses from PRRS are incurred in the growing phase of production.2 Therefore, controlling the disease during this production phase is critical.
Implementation of PRRS control protocols like Load -Close -Homogenize (LCH) in sow herds along with ongoing pig vaccination with modi- fied live vaccine have been documented as a successful methodology to achieve sustained PRRS control in large production systems.
The objective of this study was to improve finishing pig survivability, growth, and/or cull rate through the strategic use of Ingelvac PRRS MLV as compared to contemporary non-vaccinated control pigs.
Read the full publication here.